Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | ACHE | P22303 | 4/20 | 1.00 |
| ▸ | APEX1 | P27695 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.92 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.73 |
| ▸ | APAF1 | O14727 | 1/20 | 0.65 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.65 |
| ▸ | RAD52 | P43351 | 1/20 | 0.65 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30019398 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL6933263 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL17898629 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL17898630 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL6931794 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Decamethonium SCHEMBL238400 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL8208718 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12126378 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Hexamethonium SCHEMBL34900 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12198121 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 800 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250001404-A1 | Method of Synthesizing Aluminum-Rich Molecular Sieve of *MRE Framework Type | ExxonMobil Technology and Engineering Company | 2025-01-02 | — | — | US | claimed |
| EP-4244189-A1 | METHOD OF SYNTHESIZING ALUMINUM-RICH MOLECULAR SIEVE OF *MRE FRAMEWORK TYPE | ExxonMobil Technology and Engineering Company (US) | 2023-09-20 | — | — | EP | claimed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| EP-4065513-A1 | ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS | BASF CORPORATION (US) | 2022-10-05 | — | — | EP | claimed |
| WO-2022173419-A1 | ZEOLITE STRUCTURE SYNTHESIZED USING MIXTURES OF ORGANIC STRUCTURE DIRECTING AGENTS | BASF CORPORATION (US) | 2022-08-18 | — | — | WO | claimed |
| WO-2022103468-A1 | METHOD OF SYNTHESIZING ALUMINUM-RICH MOLECULAR SIEVE OF *MRE FRAMEWORK TYPE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2022-05-19 | — | — | WO | claimed |
| EP-2953897-B1 | PROCESS FOR PREPARING A BORON CONTAINING ZEOLITIC MATERIAL HAVING MWW FRAMEWORK STRUCTURE | BASF SE (DE) | 2021-07-21 | — | — | EP | claimed |
| US-11033887-B2 | High charge density metallophosphate molecular sieves | UOP LLC (US) | 2021-06-15 | — | — | US | claimed |
| US-10710892-B2 | High charge density metalloaluminophosphosilicate molecular sieves | UOP LLC (US) | 2020-07-14 | — | — | US | claimed |
| US-20200030782-A1 | HIGH CHARGE DENSITY METALLOPHOSPHATE MOLECULAR SIEVES | UOP LLC | 2020-01-30 | — | — | US | claimed |
| WO-2008016477-A2 | A NOVEL MOLECULAR SIEVE COMPOSITION, A METHOD OF MAKING AND A PROCESS OF USING THE SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-02-07 | — | — | WO | claimed |
| WO-2008016456-A2 | MOLECULAR SIEVE COMPOSITION (EMM-10), ITS METHOD OF MAKING, AND USE FOR HYDROCARBON CONVERSIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-02-07 | — | — | WO | claimed |
| US-20080027256-A1 | Molecular sieve composition (EMM-10), its method of making, and use for hydrocarbon conversions | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-01-31 | — | — | US | claimed |
| US-20080027259-A1 | Molecular sieve composition (EMM-10-P), its method of making, and use for hydrocarbon conversions | EXXONMOBIL CHEMICAL PATENTS INC. | 2008-01-31 | — | — | US | claimed |
| CN-101054183-A | Method of preparing molecular sieve with EUO structure from silicon aluminum oxide powder | UNIV TAIYUAN TECHNOLOGY (CN) | 2007-10-17 | — | — | CN | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2007-04-26 | — | — | US | claimed |
| WO-2007044693-A2 | MULTI-FUNCTIONAL IONIC LIQUID COMPOSITIONS | THE UNIVERSITY OF ALABAMA (US) | 2007-04-19 | — | — | WO | claimed |
| WO-2004002430-A2 | COMBINATIONS FOR THE TREATMENT OF FUNGAL INFECTIONS | COMBINATORX INCORPORATED (US) | 2004-01-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11033887-B2 | High charge density metallophosphate molecular sieves | LEO1, RPS3A, AP2M1 | MEN1 3969/4885KMT2A 377/4885ACHE 459/4885 |
| US-20070093462-A1 | Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients | SLC5A6, PNLIP, IPMK | MEN1 3114/4885KMT2A 4574/4885ACHE 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.